Profile data is unavailable for this security.
About the company
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.
- Revenue in USD (TTM)7.66bn
- Net income in USD771.00m
- Incorporated1996
- Employees47.00k
- LocationQuest Diagnostics Inc500 Plaza DrSECAUCUS 07094-3619United StatesUSA
- Phone+1 (973) 520-2700
- Fax+1 (302) 655-5049
- Websitehttps://www.questdiagnostics.com/
More ▼
Mergers & acquisitions
| Acquired company | DGX:NYQ since announced | Transaction value |
|---|---|---|
| Mid America Clinical Laboratories LLC | 5.58% | -- |
| Memorial Hermann Healthcare System-Laboratories & Service Centers | 7.65% | -- |
| Blueprint Genetics Oy | 8.11% | -- |
Data delayed at least 15 minutes, as of Jul 03 2020 00:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NeoGenomics, Inc. | 419.28m | 3.45m | 3.74bn | 1.70k | 1,064.07 | 7.07 | 108.05 | 8.93 | 0.0318 | 0.0318 | 3.98 | 4.79 | 0.6626 | 14.90 | 4.59 | 246,637.10 | 0.5455 | -0.0738 | 0.6136 | -0.083 | 46.77 | 45.16 | 0.8233 | -0.1135 | 2.88 | 3.16 | 0.1694 | -- | 47.73 | 36.25 | 31.50 | 47.88 | 39.64 | -- |
| 1life Healthcare Inc | 292.00m | -79.74m | 4.83bn | 1.70k | -- | 10.07 | -- | 16.55 | -0.6514 | -0.6514 | 2.39 | 3.80 | -- | -- | -- | 171,767.10 | -- | -- | -- | -- | 37.88 | -- | -27.81 | -- | 4.75 | -- | 0.0047 | -- | 29.89 | -- | -18.32 | -- | -- | -- |
| LHC Group, Inc. | 2.09bn | 98.89m | 5.60bn | 15.17k | 55.98 | 3.85 | 40.76 | 2.68 | 3.17 | 3.17 | 66.91 | 45.99 | 0.9893 | -- | 6.74 | 137,806.70 | 5.59 | 6.26 | 6.67 | 7.56 | 36.61 | 37.09 | 5.65 | 4.90 | -- | 14.42 | 0.1635 | 0.00 | 14.93 | 23.18 | 50.57 | 34.39 | -16.35 | -- |
| Encompass Health Corp | 4.66bn | 342.40m | 6.18bn | 31.57k | 17.99 | 4.28 | 9.44 | 1.32 | 3.45 | 3.45 | 46.94 | 14.53 | 0.7956 | -- | 8.93 | 147,703.50 | 7.33 | 7.24 | 9.13 | 8.99 | 96.28 | 96.19 | 9.21 | 8.91 | -- | 4.23 | 0.6474 | 33.98 | 7.66 | 14.17 | 23.32 | 11.49 | 16.55 | 7.12 |
| Amedisys Inc | 1.98bn | 127.33m | 6.61bn | 21.30k | 53.02 | 9.73 | 44.29 | 3.34 | 3.85 | 3.85 | 59.86 | 20.98 | 1.51 | -- | 7.84 | 92,956.71 | 9.78 | 8.57 | 12.78 | 11.69 | 41.37 | 41.16 | 6.48 | 4.28 | -- | 19.49 | 0.3651 | 0.00 | 17.63 | 10.18 | 6.27 | 57.73 | -8.06 | -- |
| Livongo Health Inc | 206.96m | -45.94m | 7.12bn | 671.00 | -- | 14.13 | -- | 34.41 | -0.5023 | -0.5023 | 2.25 | 5.15 | 0.5506 | 3.91 | 5.03 | 336,520.30 | -12.21 | -- | -13.67 | -- | 73.85 | -- | -22.17 | -- | 10.23 | -- | 0.00 | -- | 148.71 | -- | -65.05 | -- | -- | -- |
| Chemed Corporation | 1.99bn | 231.15m | 7.42bn | 16.64k | 33.41 | 10.80 | 26.50 | 3.72 | 13.99 | 13.99 | 120.59 | 43.28 | 1.70 | 198.26 | 15.67 | 119,723.50 | 19.69 | 15.65 | 24.54 | 19.61 | 32.19 | 30.62 | 11.60 | 8.63 | 0.7761 | 49.81 | 0.1897 | 11.96 | 8.75 | 5.89 | 7.00 | 17.23 | 4.00 | 8.10 |
| Universal Health Services, Inc. | 11.40bn | 720.84m | 7.95bn | 67.70k | 11.42 | 1.47 | 6.47 | 0.697 | 8.19 | 8.19 | 129.72 | 63.74 | 0.9771 | -- | 7.38 | 168,442.20 | 6.29 | 7.38 | 7.40 | 8.67 | -- | -- | 6.44 | 7.51 | 0.9892 | 6.38 | 0.4094 | 5.61 | 5.63 | 6.76 | 5.20 | 8.32 | 10.13 | 14.87 |
| Davita Inc | 11.49bn | 816.13m | 9.87bn | 65.00k | 13.92 | 5.07 | 5.96 | 0.8594 | 5.82 | 6.35 | 79.86 | 15.99 | 0.5714 | 79.28 | 6.09 | 176,717.00 | 5.15 | 4.47 | 7.67 | 5.80 | 31.01 | 29.49 | 9.01 | 7.13 | 1.77 | 4.89 | 0.7187 | 0.00 | -0.1436 | -2.30 | 14.45 | -0.492 | 3.63 | -- |
| Molina Healthcare, Inc. | 17.26bn | 717.00m | 10.78bn | 10.00k | 15.92 | 6.52 | 13.45 | 0.6245 | 11.43 | 11.43 | 275.26 | 27.92 | 2.35 | -- | 11.65 | 1,725,900.00 | 9.75 | 3.35 | 20.95 | 8.23 | 17.43 | 15.24 | 4.15 | 1.35 | -- | 12.29 | 0.5292 | 0.00 | -10.91 | 11.73 | 4.24 | 63.76 | -13.09 | -- |
| Quest Diagnostics Inc | 7.66bn | 771.00m | 15.52bn | 47.00k | 20.49 | 2.75 | 14.26 | 2.03 | 5.66 | 5.81 | 56.30 | 42.22 | 0.6385 | 44.92 | 7.47 | 162,914.90 | 6.32 | 6.90 | 7.46 | 7.97 | 34.30 | 36.96 | 9.90 | 9.70 | 1.27 | 7.34 | 0.4112 | 34.05 | 2.59 | 0.7708 | 16.13 | 8.75 | 5.37 | 10.45 |
| Laboratory Corp. of America Holdings | 11.59bn | 321.00m | 16.55bn | 65.00k | 52.40 | 2.36 | 18.26 | 1.43 | 3.25 | 3.25 | 118.22 | 72.30 | 0.6763 | 34.43 | 5.87 | 178,267.70 | 1.88 | 4.90 | 2.20 | 5.62 | 27.54 | 29.71 | 2.78 | 7.04 | 1.07 | 6.54 | 0.4725 | 0.00 | 1.95 | 13.96 | -11.29 | 10.01 | 14.48 | -- |
Data as of Jul 03 2020. Currency figures normalised to Quest Diagnostics Inc's reporting currency: US Dollar USD
39.85%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2020 | 15.10m | 11.29% |
| BlackRock Fund Advisorsas of 31 Mar 2020 | 7.64m | 5.72% |
| SSgA Funds Management, Inc.as of 31 Mar 2020 | 6.82m | 5.10% |
| American Century Investment Management, Inc.as of 31 Mar 2020 | 5.26m | 3.94% |
| Fiduciary Management, Inc.as of 31 Mar 2020 | 4.66m | 3.48% |
| Davis Selected Advisers LPas of 31 Mar 2020 | 3.87m | 2.89% |
| Victory Capital Management, Inc. (Investment Management)as of 31 Mar 2020 | 3.53m | 2.64% |
| JPMorgan Investment Management, Inc.as of 31 Mar 2020 | 2.30m | 1.72% |
| Geode Capital Management LLCas of 31 Mar 2020 | 2.20m | 1.65% |
| Dimensional Fund Advisors LPas of 31 Mar 2020 | 1.91m | 1.43% |
More ▼
Data from 31 Mar 2020 - 31 Mar 2020Source: FactSet Research Systems Inc.
